CASP1 and amyotrophic lateral sclerosis: Similarly, other research teams have reported increases in the expression and activity of NLRP3, IL-1β, IL-18 and caspase-1 in plaques of MS patients and the tissues of amyotrophic lateral sclerosis (ALS) (or motor neurone disease) patients [195, 197–199].